LEO 90110 ointment in the treatment of psoriasis vulgaris

Registry ID
EUCTR2010-021941-38
Source registry
EUCTR
Status
Prematurely Ended
Phase
PHASE2
Sponsor
LEO Pharma A/S
Start date
2010-12-09
Last update
2026-08-16

Conditions

Summary

To compare LEO 90110 20.0 mg/g ointment to LEO 90110 ointment vehicle with respect to efficacy when administered twice daily for 8 weeks to patients with psoriasis vulgaris

Locations

View on source registry